<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2166-6482</issn>
<issn pub-type="ppub">1043-3155</issn>
<issn-l>2166-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-6-50-a</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-6-7-2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Degenerative Disorders</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Rett Syndrome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Children&#x0027;s Memorial Hospital, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>07</month>
<year>1992</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>01</day>
<month>07</month>
<year>2016</year>
</pub-date>
<volume>6</volume>
<issue>7</issue>
<fpage>50</fpage>
<lpage>50</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; 1992 The Author(s)</copyright-statement>
<copyright-year>1992</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1111/j.1651-2227.1992.tb12196.x" vol="81" page="167">
<article-title>Rett syndrome: the late infantile regression period - a retrospective analysis of 91 cases</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>The late infantile regression period (stages I and II) was analyzed retrospectively in 91 girls and women at the Department of Pediatrics, University of Goteborg and Pediatric Clinic, Ostersund Hospital, Sweden.</p>
</abstract>
<kwd-group>
<kwd>Rett Syndrome</kwd>
<kwd>Pathophysiology</kwd>
<kwd>Norepinephrine</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>The late infantile regression period (stages I and II) was analyzed retrospectively in 91 girls and women at the Department of Pediatrics, University of Goteborg and Pediatric Clinic, Ostersund Hospital, Sweden. The median age at onset of developmental stagnation (stage I) was 11 months, and loss of acquired skills (stage II) began at 19 months and lasted for 19 months. The onset of regression was distinct in 43%, dramatic in 16%, and insidious in 41%. The first observed signs of disease were delay in reaching expected gross motor milestones, dissociation of motor development, and disequilibrium. A triad of manifestations characterized the deterioration or loss of acquired skills: contact/communication, hand use/skill, babble/words. End of regression occurred at mean age 2.5 years. The girls gradually became more alert and showed an interest to act and interact. Handedness showed a preference for the left hand compared to the right, and was associated with spike activity in the left central leads in the EEG in 13 of 20 girls. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<disp-quote>
<p><bold>COMMENT.</bold> This further delineation of the stages of Rett syndrome may help in the diagnosis and pathophysiology of the disorder. In a study involving the analysis of beta-endorphin, as well as lactate, pyruvate and metabolites of norepinephrine, dopamine and serotonin in CSF from 12 girls with Rett&#x2019;s syndrome, the most consistent and significant difference from a control group was the elevation of beta-endorphin immunoreactivity in the CSF. Myer EC et al. from the Department of Child Neurology, Medical College of Virginia, Richmond VA found increased levels of beta-endorphin immuno-reactivity in lumbar CSF in 90% of 158 Rett syndrome patients [<xref ref-type="bibr" rid="CIT0002">2</xref>]. The authors note that the symptoms of Rett syndrome are similar to the effects of centrally administered beta-endorphin or other opioids in experimental animals.</p>
</disp-quote>
</body>
<back>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Engerstrom</surname>
<given-names>IW</given-names>
</name>
</person-group>
<article-title>Rett syndrome: the late infantile regression period - a retrospective analysis of 91 cases</article-title>
<source>Acta Paediatr</source>
<year>1992</year>
<month>Feb</month>
<volume>81</volume>
<issue>2</issue>
<fpage>167</fpage>
<lpage>172</lpage>
<pub-id pub-id-type="doi">10.1111/j.1651-2227.1992.tb12196.x</pub-id>
<pub-id pub-id-type="pmid">1515763</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myer</surname>
<given-names>EC</given-names>
</name>
<name>
<surname>Tripathi</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Brase</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Dewey</surname>
<given-names>WL</given-names>
</name>
</person-group>
<article-title>Elevated CSF beta-endorphin immunoreactivity in Rett&#x2019;s syndrome: report of 158 cases and comparison with leukemic children</article-title>
<source>Neurology</source>
<year>1992</year>
<month>Feb</month>
<volume>42</volume>
<issue>2</issue>
<fpage>357</fpage>
<lpage>360</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.42.2.357</pub-id>
<pub-id pub-id-type="pmid">1736165</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>